Monument is a telepsychiatry platform that provides access to therapy, US Food & Drug Administration approved medication, community resources, and support groups for treatment of alcohol addiction. Patients can decide to opt for evidence-based therapy at their own time and pace.
Monument offers a tiered subscription service and personalized plans starting from USD 39 to USD 249 per month. A total care plan will include a weekly 45-min video session with a therapist, chat-based messaging with a therapist and physician, appointments with a licensed physician, prescription management, along with access to free community resources and therapist-led support groups.
Since the company’s launch in May 2020, Monument has gained over 13,000 members. The company closed a Series A funding round in January 2021, which brought its total funding to USD 17.3 million.
No investor data is available
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.